LEO Pharma has been involved in the treatment of skin infections since the development and launch (1962) of FucidinŽ. Fusidic acid exerts its antibacterial action by inhibiting the bacterial protein synthesis. FucidinŽ has a narrow spectrum of activity, but is effective against most strains of the common bacteria
FucidinŽ is available in a range of topical formulations both cream and ointment and also is available as FucidinŽ tablets, FucidinŽ suspension and IV infusion.
LEO Pharma is a trade name of LEO Laboratories Ltd. 285 Cashel Road, Dublin 12. Ireland (Registered Office) Registered in Ireland (No. 16885) · Phone +353 1 4908924 · Fax +353 1 4901606
/(E100A3479E2D2A0D9B0B186CE59A1ABD)/$File/menuHome.gif){kind=small}
/(E100A3479E2D2A0D9B0B186CE59A1ABD)/$File/menuIndicator2.gif){kind=small}
/(E100A3479E2D2A0D9B0B186CE59A1ABD)/$File/topOfLeftMenu.gif){kind=small}
/(E100A3479E2D2A0D9B0B186CE59A1ABD)/$File/print.gif){kind=small}
/(E100A3479E2D2A0D9B0B186CE59A1ABD)/$File/h_line.gif){kind=small}
/(E100A3479E2D2A0D9B0B186CE59A1ABD)/$File/top.gif){kind=small}
Sitemap